Trial Profile
A Phase 1, Randomized, Blinded, Placebo and Moxifloxacin Controlled, 4-Period Crossover, Study Evaluating the Effect of ZTI-01 on 12-Lead Electrocardiogram Parameters in Healthy Adult Subject
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Fosfomycin (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Skin and soft tissue infections; Urinary tract infections
- Focus Adverse reactions
- Sponsors Nabriva Therapeutics; Zavante Therapeutics
- 26 Oct 2018 New trial record